Three bottles of vodka? How to cut Aussie cancer deaths by 4%
If Australians cut their alcohol consumption by 1L of pure alcohol a year, deaths from four key cancers…
JPM26: J&J reveals oncology strategy
CEO Joaquin Duato presented a strong outlook for Johnson & Johnson’s (J&J) revenue growth in 2026, with particular…
Durvalumab extends survival in small cell lung cancer but raises cost concerns
A new study suggests that the immune checkpoint inhibitor, durvalumab, may offer new treatment options for patients living…
Dinutuximab beta plus chemotherapy shrinks neuroblastoma tumors in children
Children with a rare form of cancer called neuroblastoma which hasn’t responded to initial treatment or that has…
Discovery links human M cells to early steps of celiac disease
The human small intestine absorbs nutrients while protecting us from potentially harmful microbes. One of the cell types…
AI model improves recurrence risk stratification in HR-positive, HER2-negative breast cancer
An artificial intelligence (AI) model created by integrating clinical, molecular, and histopathological data significantly improved recurrence risk stratification…
Triaptosis-based therapeutic innovations could offer renewed hope for cancer patients
Cancer remains one of the most critical global public health challenges, exerting profound social, economic, and clinical burdens…
Autoimmune thyroiditis promotes breast cancer progression: exploratory role of thyroid hormone receptor beta signaling disruption | Breast Cancer Research
Turken O, NarIn Y, DemIrbas S, Onde ME, Sayan O, KandemIr EG, et al. Breast cancer in association…
Cardiovascular disease risk following radiotherapy among breast cancer survivors: a nationwide cohort study in South Korea | Breast Cancer Research
Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022:…
ASAH1-mediated sphingolipid metabolic reprogramming in venetoclax resistance of AML: beyond the monocytic phenotypes | BMC Cancer
Lagadinou ED, Sach A, Callahan K, et al. BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human…
Assessing patterns of authorship of low- and middle-income countries in global commercial clinical trials in oncology | Globalization and Health
Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022:…
Landmark prostate cancer screening trial launches in the UK
The first men have been invited to take part in Prostate Cancer UK’s TRANSFORM trial, kicking off the…